NSE - Delayed Quote INR

Pfizer Limited (PFIZER.NS)

Compare
4,069.90
+22.55
+(0.56%)
At close: 3:30:00 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
22,355,900
21,926,900
24,223,200
26,109,900
22,384,300
Cost of Revenue
7,999,700
7,952,300
8,756,500
9,480,300
7,997,900
Gross Profit
14,356,200
13,974,600
15,466,700
16,629,600
14,386,400
Operating Expense
7,875,600
8,204,000
8,378,900
9,422,300
8,304,000
Operating Income
6,480,600
5,770,600
7,087,800
7,207,300
6,082,400
Net Non Operating Interest Income Expense
1,589,000
1,561,600
720,100
-104,900
233,500
Pretax Income
8,341,500
7,460,700
8,240,100
7,728,900
6,687,200
Tax Provision
2,186,300
1,947,400
2,000,800
1,603,300
1,711,100
Net Income Common Stockholders
6,155,200
5,513,300
6,239,300
6,125,600
4,976,100
Diluted NI Available to Com Stockholders
6,155,200
5,513,300
6,239,300
6,125,600
4,976,100
Basic EPS
134.53
120.51
136.38
133.89
108.77
Diluted EPS
134.53
120.51
136.38
133.89
108.77
Basic Average Shares
45,754.54
45,750.37
45,750.37
45,750.99
45,750.37
Diluted Average Shares
45,754.54
45,750.37
45,750.37
45,750.99
45,750.37
Rent Expense Supplemental
--
3,300
1,900
3,300
5,000
Total Expenses
15,875,300
16,156,300
17,135,400
18,902,600
16,301,900
Net Income from Continuing & Discontinued Operation
6,155,200
5,513,300
6,239,300
6,125,600
4,976,100
Normalized Income
6,173,573.73
5,472,950.60
5,957,697.32
6,125,600
4,935,397.73
Interest Income
--
1,715,900
854,900
489,400
387,400
Interest Expense
79,900
107,300
133,900
104,900
151,100
Net Interest Income
1,589,000
1,561,600
720,100
-104,900
233,500
EBIT
8,421,400
7,568,000
8,374,000
7,833,800
6,838,300
EBITDA
9,002,800
8,190,800
9,429,100
8,983,800
7,932,400
Reconciled Cost of Revenue
7,999,700
7,952,300
8,756,500
9,480,300
7,997,900
Reconciled Depreciation
581,400
622,800
1,055,100
1,150,000
1,094,100
Net Income from Continuing Operation Net Minority Interest
6,155,200
5,513,300
6,239,300
6,125,600
4,976,100
Total Unusual Items Excluding Goodwill
-24,900
54,600
371,900
--
54,700
Total Unusual Items
-24,900
54,600
371,900
--
54,700
Normalized EBITDA
9,027,700
8,136,200
9,057,200
8,983,800
7,877,700
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-6,526.27
14,250.60
90,297.32
--
13,997.73
3/31/2021 - 7/1/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SANOFICONR.NS SANOFI CONS HEALTHC IND L
4,803.20
+0.10%
 
SANOFI.NS Sanofi India Limited
6,003.15
+2.16%
 
GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited
2,856.75
+2.89%
 
PFE.NE Pfizer Inc.
11.37
-0.35%
 
ROG.SW Roche Holding AG
278.50
-2.89%
 
PFE Pfizer Inc.
24.61
-0.38%
 
NVO Novo Nordisk A/S
67.60
-0.93%
 
JNJ Johnson & Johnson
159.36
+2.57%